[1] Worldometers.COVID-19 coronavirus pandemic.[EB/OL].(2021-06-01)[2021-06-01]. https://www.worldometers.info/coronavirus/. [2] Ji Y, Ma Z, Peppelenbosch MP, et al.Potential association between COVID-19 mortality and health-care resource availability[J]. Lancet Glob Health, 2020: 8(4): e480. [3] Baud D, Qi X, Nielsen-Saines K, et al.Real estimates of mortality following COVID-19 infection[J]. Lancet Infect Dis, 2020, 20(7): 773. [4] Zhu N, Zhang D, Wang W, et al.A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8): 727-733. [5] Millet JK, Whittaker GR.Host cell entry of middle east respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein[J]. Proc Natl Acad Sci USA, 2014, 111(42): 15214-15219. [6] Belouzard S, Chu VC, Whittaker GR.Activation of the SARS corona-virus spike protein via sequential proteolytic cleavage at two distinct sites[J]. Proc Natl Acad Sci USA, 2009, 6(14): 5871-5876. [7] Walls AC, Tortorici MA, Snijder J, et al.Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion[J]. Proc Natl Acad Sci USA, 2017, 114(42): 11157-11162. [8] Wrapp D, Wang N, Corbett KS, et al.Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation[J]. Science, 2020, 367(6483): 1260-1263. [9] Walls AC, Park YJ, Tortorici MA, et al.Structure, function, and Antigenicity of the SARS-CoV-2 spike glycoprotein[J]. Cell, 2020, 181(2): 281-292. [10] Letko M, Marzi A, Munster V.Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses[J]. Nat Microbiol, 2020, 5(4): 562-569. [11] Yan R, Zhang Y, Li Y, et al.Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2[J]. Science, 2020, 367(6485): 1444-1448. [12] Heurich A, Hofmann-Winkler H, Gierer S, et al.TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein[J]. J Virol, 2014, 88(2): 1293-1307. [13] Bertram S, Heurich A, Lavender H, et al.Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts[J]. PLoS One, 2012, 7(4): e35876. [14] Liu J, Li S, Liu J, et al.Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients[J]. EBio Medicine, 2020, 55: 102763. [15] Huang C, Wang Y, Li X, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506. [16] Ruan Q, Yang K, Wang W, et al.Correction to: clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China[J]. Intensive Care Med, 2020, 46(6): 1294-1297. [17] Anasiz Y, Ozgul RK, Uckan-Cetinkaya D.A new chapter for mesenchymal stem cells: decellularized extracellular matrices[J]. Stem Cell Rev Rep, 2017, 13(5): 587-597. [18] Alstrup T, Eijken M, Bohn AB, et al.Isolation of adipose tissue -derived stem cells:enzymatic digestion in combination with mechanical distortion to increase adipose tissue-derived stem cell yield from human aspirated fat[J]. Curr Protoc Stem Cell Biol, 2019, 48(1): e68. [19] Bieback K, Netsch P.Isolation, culture, and characterization of human umbilical cord blood-derived mesenchymal stromal cells[J]. Methods Mol Biol, 2016, 1416: 245-258. [20] Li J, Xu SQ, Zhao YM, et al.Comparison of the biological characteristics of human mesenchymal stem cells derived from exfoliated deciduous teeth, bone marrow, gingival tissue, and umbilical cord[J]. Mol Med Rep, 2018, 18(6): 4969-4977. [21] Ankrum JA, Ong JF, Karp JM.Mesenchymal stem cells: immune evasive, not immune privileged[J]. Nat Biotechnol, 2014, 32(3): 252-260. [22] Nauta AJ, Fibbe WE.Immunomodulatory properties of mesenchymal stromal cells[J]. Blood, 2007, 110(10): 3499-3506. [23] Koç ON, Day J, Nieder M, et al.Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)[J]. Bone Marrow Transplant, 2002, 30(4): 215-222. [24] Pinheiro D, Dias I, Freire T, et al.Effects of mesenchymal stem cells conditioned medium treatment in mice with cholestatic liver fibrosis[J]. Life Sci, 2021, 281: 119768. [25] Khoury M, Cuenca J, Cruz FF, et al.Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19[J]. Eur Respir J, 2020, 55(6): 2000858. [26] Chan MC, Kuok DI, Leung CY, et al.Human mesenchymal stromalcells reduce influenza A H5N1-associated acute lung injury in vitroand in vivo[J]. Proc Natl Acad Sci USA, 2016, 113(13): 3621-3626. [27] Li Y, Xu J, Shi W, et al.Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice[J]. Stem Cell Res Ther, 2016, 7(1): 159. [28] Chen J, Hu C, Chen L, et al.Clinical study of mesenchymal stem cell treatment for acute respiratory distress syndrome induced by epidemic influenza A (H7N9) infection: a hint for COVID-19 treatment[J]. Engineering (Beijing), 2020, 6(10): 1153-1161. [29] Neidlinger-Wilke C, Ekkerlein A, Goncalves RM, et al.Mesench-ymal stem cell secretome decreases the inflammatory response in annulus fibrosus organ cultures[J]. Eur Cell Mater, 2021, 41: 1-19. [30] English K.Mechanisms of mesenchymal stromal cell immunom-odulation[J]. Immunol Cell Biol,2013, 91(1): 19-26. [31] Sohni A, Verfaillie CM.Mesenchymal stem cells migration homing and tracking[J]. Stem Cells Int, 2013: 130763. [32] Meng F, Xu R, Wang S, et al.Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial[J]. Signal Transduct Target Ther, 2020, 5(1): 172. [33] Leng Z, Zhu R, Hou W, et al.Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 Pneumonia[J]. Aging Dis, 2020, 11(2): 216-228. [34] Chen L, Zhang W, Yue H, et al.Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells[J]. Stem Cells Dev, 2007, 16(5): 719-731. [35] Zhang B, Liu R, Shi D, et al.Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population[J]. Blood, 2009, 113(1): 46-57. [36] Shi X, Mao J, Liu Y.Pulp stem cells derived from human permanent and deciduous teeth: Biological characteristics and therapeutic applications[J]. Stem Cells Transl Med, 2020, 9(4): 445-464. [37] Yeo RW, Lai RC, Zhang B, et al.Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery[J]. Adv Drug Deliv Rev, 2013, 65(3): 336-341. [38] Kim HS, Choi DY, Yun SJ, et al.Proteomicanalysis of microvesicles derived from human mesenchymal stem cells[J]. J Proteome Res, 2012, 11(2): 839-849. [39] Phinney DG, Di Giuseppe M, Njah J, et al.Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs[J]. Nat Commun, 2015, 6: 8472. [40] Zhu YG, Feng XM, Abbott J, et al.Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice[J]. Stem Cells, 2014, 32(1): 116-125. [41] Jia Y, Lu T, Chen Q, et al.Exosomes secreted from sonic hedgehog-modified bone mesenchymal stem cells facilitate the repair of rat spinal cord injuries[J]. Acta Neurochir (Wien), 2021, 163(8): 2297-2306. [42] Zhang E, Geng X, Shan S, et al.Exosomes derived from bone marrow mesenchymal stem cells reverse epithelial-mesenchymal transition potentially via attenuating Wnt/β-catenin signaling to alleviate silica-induced pulmonary fibrosis[J]. Toxicol Mech Methods, 2021, 5: 1-40. [43] Lee RH, Pulin AA, Seo MJ, et al.Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6[J]. Cell Stem Cell, 2009, 5(1): 54-63. [44] Qian X, Xu C, Fang S, et al.Exosomal micrornas derived from umbilical mesenchymal stem cells inhibit hepatitis cvirus infection[J]. Stem Cells Transl Med, 2016, 5(9): 1190-1203. [45] Liang B, Chen J, Li T, et al.Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report[J]. Medicine (Baltimore), 2020, 99(31): e21429. |